Form 4 Filing for ARTELO BIOSCIENCES, INC.

This filing details a Form 4 submission for ARTELO BIOSCIENCES, INC. by reporting owner Blayney Douglas, who is a director. The transaction, dated July 17, 2026, involves the acquisition of 136 shares of Common Stock through the exercise of a stock option. The option, with an exercise price of $1.15, was granted with a vesting commencement date of July 17, 2026, and is set to expire on July 17, 2036. The option vests fully on the earlier of the one-year anniversary of the vesting commencement date or the day prior to the next annual stockholders' meeting, provided the reporting person remains a service provider. Post-transaction, the reporting owner holds 136 shares. The filing was signed by Gregory D. Gorgas as Attorney-in-Fact on July 21, 2026.